Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$125,988,484
-$16,946,055 QoQ
Shares Held
3,781,167
-8.5% QoQ
Ownership
4.30%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 12.690552943046418.ToString("F0")%
Shared 0.018512803057891915.ToString("F0")%
None 87.29093425389568.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. IDYA ranks #55 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in IDYA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $125,988,484 | 3,781,167 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $142,934,539 | 4,134,641 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $88,185,814 | 3,240,934 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $71,169,389 | 3,385,794 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $56,449,247 | 3,446,230 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $85,347,078 | 3,320,898 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $105,112,212 | 3,317,936 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $100,916,532 | 2,874,296 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $138,834,301 | 3,163,954 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $106,451,766 | 2,991,899 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $57,939,550 | 2,147,500 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $50,254,820 | 2,138,503 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $29,029,572 | 2,114,317 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $42,202,386 | 2,322,641 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $28,353,684 | 1,900,381 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $20,453,725 | 1,482,154 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $20,929,440 | 1,870,370 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $40,015,593 | 1,692,707 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $26,501,978 | 1,039,701 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,000,506 | 381,158 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,900,098 | 251,068 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $3,218,936 | 229,924 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,613,535 | 208,084 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $2,387,649 | 168,026 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||